lhrh antagonists to low-dose treatment of neurodegenerative diseases, particularly alzheimer's disease

摘要

The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.